These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors. Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730 [TBL] [Abstract][Full Text] [Related]
8. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma. Siriwardena BS; Kudo Y; Ogawa I; Tilakaratne WM; Takata T Oral Oncol; 2009 Feb; 45(2):103-8. PubMed ID: 18486530 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review Based Evidence to Consider It as a New Sub Type of Ameloblastoma. Jayasooriya PR; Abeyasinghe WAMUL; Liyanage RLPR; Uthpali GN; Tilakaratne WM Head Neck Pathol; 2022 Jun; 16(2):344-352. PubMed ID: 34282559 [TBL] [Abstract][Full Text] [Related]
10. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma. Mendez LD; Wolsefer NS; Asa SL; Wasman J; Yoest JM; Stojanov IJ Mod Pathol; 2022 Nov; 35(11):1570-1577. PubMed ID: 35676332 [TBL] [Abstract][Full Text] [Related]
14. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma]. Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087 [No Abstract] [Full Text] [Related]
15. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts. Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674 [TBL] [Abstract][Full Text] [Related]
16. Adenoid Ameloblastoma vs Dentinogenic Ghost Cell Tumor: Are They Related Entities? Bastos VC; Guimarães LM; Gomes CC; Gomez RS Mod Pathol; 2023 Apr; 36(4):100132. PubMed ID: 36924756 [No Abstract] [Full Text] [Related]
18. Unicystic adenoid ameloblastoma: A new variant? Martins-Chaves RR; Coura BP; Gomes CC; Fonseca FP; de Castro WH; Gomez RS Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jul; 134(1):e23-e28. PubMed ID: 35153188 [TBL] [Abstract][Full Text] [Related]
19. A rare case of peripheral adenoid ameloblastoma with dentinoid. Alramadhan SA; Ruddocks LA; Bhattacharyya I; Cohen DM; Islam MN Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jan; 135(1):e10-e13. PubMed ID: 36396590 [TBL] [Abstract][Full Text] [Related]
20. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology. Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423 [No Abstract] [Full Text] [Related] [Next] [New Search]